Current evidence for new oral anticoagulants in the treatment of nonvalvular atrial fibrillation: comparison of substudies.

作者信息

Martínez-Rubio Antoni, Martínez-Torrecilla Roger

机构信息

Departamento de Cardiología, Hospital Universitario de Sabadell, Barcelona, Spain; Departamento de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Departamento de Cardiología, Hospital Universitario de Sabadell, Barcelona, Spain.

出版信息

Rev Esp Cardiol (Engl Ed). 2015 Mar;68(3):185-9. doi: 10.1016/j.rec.2014.07.016. Epub 2014 Nov 7.

DOI:10.1016/j.rec.2014.07.016

PMID:25449814

Abstract

摘要

相似文献

Current evidence for new oral anticoagulants in the treatment of nonvalvular atrial fibrillation: comparison of substudies.

Rev Esp Cardiol (Engl Ed). 2015 Mar;68(3):185-9. doi: 10.1016/j.rec.2014.07.016. Epub 2014 Nov 7.

Oral anticoagulants for stroke prevention in atrial fibrillation. Foreword.

Curr Probl Cardiol. 2014 Sep;39(9):317. doi: 10.1016/j.cpcardiol.2014.07.002. Epub 2014 Jul 16.

Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants?

Int J Clin Pract. 2012 May;66(5):422-4. doi: 10.1111/j.1742-1241.2011.02815.x.

[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].

Anadolu Kardiyol Derg. 2007 Mar;7(1):54-8.

[Consensus statement: Stroke prevention in nonvalvular atrial fibrillation in special consideration of the new direct oral anticoagulants].

Wien Klin Wochenschr. 2014 Dec;126(23-24):792-808. doi: 10.1007/s00508-014-0586-5. Epub 2014 Oct 3.

Stroke and recurrent left atrial appendage thrombus in a patient with atrial fibrillation under old and new oral anticoagulants: a case report.

Thromb Haemost. 2014 Feb;111(2):375-8. doi: 10.1160/TH13-06-0446. Epub 2013 Oct 17.

Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.

Thromb Res. 2012 Jan;129(1):9-16. doi: 10.1016/j.thromres.2011.09.023. Epub 2011 Oct 21.

New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.

Neurol Clin. 2013 Aug;31(3):659-75. doi: 10.1016/j.ncl.2013.03.001.

Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation.

Cardiovasc Ther. 2014 Apr;32(2):74-81. doi: 10.1111/1755-5922.12048.

Overview of the non-vitamin K oral anticoagulants for atrial fibrillation.

Ther Adv Cardiovasc Dis. 2017 Mar;11(3):77-79. doi: 10.1177/1753944717690481.

引用本文的文献

Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation: Assessment, Monitoring and Treatment Reversal.

Eur Cardiol. 2016 Dec;11(2):118-122. doi: 10.15420/ecr.2016:30:1.

Cardiovascular Pharmacotherapies Focus: Are low doses of direct-acting oral anticoagulants justified and appropriate in patients with nonvalvular atrial fibrillation?

Eur Cardiol. 2016 Dec;11(2):115-117. doi: 10.15420/ecr.2016.11.2.ED2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验